Form 4: Accelerate Diagnostics Executive Sells Shares to Cover Tax Obligations

Sentiment:

SEC Form 4 Filing


Larry Michael Mertz, Chief Technology Officer of Accelerate Diagnostics, sold shares to cover tax withholding obligations related to vesting restricted stock units.

Summary

  • On April 4, 2025, Larry Michael Mertz, the Chief Technology Officer of Accelerate Diagnostics, sold 1,523 shares of common stock at a price of $0.65 per share.
  • This sale was to cover tax withholding obligations associated with the vesting and settlement of 4,298 restricted stock units (RSUs).
  • Mertz also acquired 4,298 shares through the vesting of these RSUs on the same date.
  • Following these transactions, Mertz directly owns 84,803 shares of Accelerate Diagnostics common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction (selling shares to cover taxes on vested stock), so the sentiment is neutral.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential sentiment.

Stakeholder Impact

  • The sale of shares by an executive could be perceived negatively by some shareholders, although it is a common practice to cover tax obligations.

Key Dates

DateDescription
04/04/2022Reporting person was granted a total of 7,164 RSUs, of which 40% vest on April 4, 2024 and the remaining 60% vest on April 4, 2025.
04/04/202440% of the 7,164 RSUs granted on April 4, 2022 vested.
04/04/2025Transaction date: Mertz sold 1,523 shares at $0.65 and acquired 4,298 shares through RSU vesting; remaining 60% of the 7,164 RSUs granted on April 4, 2022 vested.
04/07/2025Date of Form 4 signature.

Keywords

Accelerate Diagnostics, Larry Michael Mertz, Form 4, Stock Sale, Restricted Stock Units, Tax Obligations, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.